🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study

Recruitingn/aAges 20 Years - anyAllNational Cancer Center, Japan
NCT05433753 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study will assess minimal residual disease (MRD) in HER2-positive early breast cancer patients in Asian countries. The purpose is to evaluate the relation between the detection rate of MRD and recurrence.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age of 20 years or older at the date of registration. 2. Histological diagnosis of HER2-positive invasive breast carcinoma. 3. Patients scheduled for neoadjuvant chemotherapy followed by surgery. 4. Clinical Stage IIA-IIIC. 5. Known hormone receptor status. 6. Signed informed consent. Exclusion Criteria: 1. Any other malignancy within 5 years prior to registration, except for adequately treated basal cell or squamous cell skin cancer, or carcinoma in situ of the esophagus, stomach, colon, or cervix. 2. Bilateral synchronous breast cancer. 3. History of breast cancer. 4. Pregnancy at registration.
💊

What it tests

  • Not listed
📍

Where

1 site
National Cancer Center Hospital, Japan
Chuo-ku, Japan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy